Latest filing published 03 Feb 2023 for Kalaris Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Ann M. Leen: trading record in brief
Ann M. Leen is a declared insider of Kalaris Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 3 August 2020 to 2 February 2023, the count stands at 30 filings.
Sales make up the whole of the open-market record (22 sales, €4.5M). Other entries cover 5 share grants.
Most recently, on 3 February 2023, the filings show a share grant in Kalaris Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ann M. Leen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,000 shares0Common StockSEC:0001209191-23-006990:1
- 43,750 shares0Common StockSEC:0001209191-23-006990:2
- 23,256 shares0Common StockSEC:0001209191-23-006990:0
- 15,000 shares0Common StockSEC:0000899243-22-029062:0
- 500 shares@ US$23.180.3% of flowCommon StockSEC:0000899243-21-044889:1
- 6,122 shares@ US$21.923.1% of flowCommon StockSEC:0000899243-21-044889:2
- 100 shares@ US$21.760.1% of flowCommon StockSEC:0000899243-21-044889:3
- 14,266 shares@ US$22.26479.0% of flowCommon StockSEC:0000899243-21-044889:0
- 150,000 shares@ US$22.7591.0% of flowCommon StockSEC:0001209191-21-031337:0
- 3,025 shares@ US$30.002.0% of flowCommon StockSEC:0001209191-21-021808:0
- 6,359 shares@ US$38.465.3% of flowCommon StockSEC:0001209191-21-017527:0
- 3,159 shares@ US$39.182.7% of flowCommon StockSEC:0001209191-21-017527:1
- 1,492 shares@ US$38.831.2% of flowCommon StockSEC:0001209191-21-013484:3
- 1,907 shares@ US$39.591.6% of flowCommon StockSEC:0001209191-21-013484:4
- 800 shares@ US$40.560.7% of flowCommon StockSEC:0001209191-21-013484:5
- 7,541 shares@ US$41.75Common StockSEC:0001209191-21-013484:0
- 1,200 shares@ US$41.54Common StockSEC:0001209191-21-013484:1
- 4,506 shares@ US$42.84Common StockSEC:0001209191-21-013484:2
- 300 shares@ US$39.200.3% of flowCommon StockSEC:0000899243-21-007336:0
- 1,100 shares@ US$40.441.0% of flowCommon StockSEC:0000899243-21-007336:1
- 1,300 shares@ US$41.50Common StockSEC:0000899243-21-007336:2
- 500 shares@ US$38.630.4% of flowCommon StockSEC:0000899243-21-007275:2
- 400 shares@ US$39.850.3% of flowCommon StockSEC:0000899243-21-007275:3
- 2,850 shares@ US$41.82Common StockSEC:0000899243-21-007275:0
- 200 shares@ US$42.79Common StockSEC:0000899243-21-007275:1
25 of 30 declarations
